BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 38653751)

  • 1. Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration.
    Nguyen QD; Das A; Do DV; Dugel PU; Gomes A; Holz FG; Koh A; Pan CK; Sepah YJ; Patel N; MacLeod H; Maurer P
    Ophthalmology; 2020 Jul; 127(7):963-976. PubMed ID: 32107066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal transient hyporeflectivity in neovascular age-related macular degeneration and its response to a loading phase of aflibercept: PRECISE report 4.
    Montesel A; Pakeer Muhammed R; Chandak S; Kazantzis D; Thottarath S; Chandra S; Chong V; Burton BJL; Menon G; Pearce I; McKibbin M; Kotagiri A; Talks J; Grabowska A; Ghanchi F; Gale R; Giani A; Yamaguchi TCN; Sivaprasad S
    Eye (Lond); 2024 Apr; ():. PubMed ID: 38653751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUBRETINAL TRANSIENT HYPOREFLECTIVITY IN AGE-RELATED MACULAR DEGENERATION: A Spectral Domain Optical Coherence Tomography Study.
    Astroz P; Miere A; Amoroso F; Semoun O; Khorrami A; Srour M; Querques G; Souied EH
    Retina; 2022 Apr; 42(4):653-660. PubMed ID: 34907127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmental Exudative Dynamics in Neovascular Age-Related Macular Degeneration: Volumetric Outcomes and Impact of Volatility in a Phase III Clinical Trial.
    Ehlers JP; Lunasco LM; Yordi S; Cetin H; Le TK; Sarici K; Kaiser PK; Khanani AM; Talcott KE; Hu J; Meng X; Srivastava SK
    Ophthalmol Retina; 2024 Feb; ():. PubMed ID: 38403242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Fluid Volatility With Subretinal Hyperreflective Material and Ellipsoid Zone Integrity in Neovascular AMD.
    Ehlers JP; Patel N; Kaiser PK; Heier JS; Brown DM; Meng X; Reese J; Lunasco L; Le TK; Hu M; Srivastava SK
    Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):17. PubMed ID: 35713892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluid Control in Neovascular Age-Related Macular Degeneration with Brolucizumab: An Analysis of the HAWK and HARRIER Phase 3 Trials.
    Regillo C; Singh R; Hamilton R; Gedif K; Best C; Koh A; Holz FG
    Ophthalmologica; 2022; 245(5):403-412. PubMed ID: 35468601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFECT OF RANIBIZUMAB AND AFLIBERCEPT ON RETINAL PIGMENT EPITHELIAL DETACHEMENT, SUBRETINAL AND INTRARETINAL FLUID IN AGE-RELATED MACULAR DEGENERATION.
    Sumarová P; Ovesná P; Matušková V; Beránek J; Michalec M; Michalcová L; Autrata D; Vysloužilová D; Chrapek O
    Cesk Slov Oftalmol; 2022; 78(4):176-185. PubMed ID: 35922146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review.
    Hanson RLW; Airody A; Sivaprasad S; Gale RP
    Eye (Lond); 2023 Aug; 37(12):2438-2453. PubMed ID: 36526863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Findings of uncertain significance by optical coherence tomography (OCT) as prognostic factors in neovascular age-related macular degeneration (nAMD) treated with ranibizumab.
    Hayashi-Mercado R; Pérez-Montaño C; Reyes-Sánchez J; Ramírez-Estudillo A
    Int J Retina Vitreous; 2022 Apr; 8(1):29. PubMed ID: 35449032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal Imaging Features and Clinical Relevance of Subretinal Lipid Globules.
    Fernández-Avellaneda P; Freund KB; Wang RK; He Q; Zhang Q; Fragiotta S; Xu X; Ledesma-Gil G; Sugiura Y; Breazzano MP; Yannuzzi LA; Liakopoulos S; Sarraf D; Dolz-Marco R
    Am J Ophthalmol; 2021 Feb; 222():112-125. PubMed ID: 32918902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.
    Schmidt-Erfurth U; Klimscha S; Waldstein SM; Bogunović H
    Eye (Lond); 2017 Jan; 31(1):26-44. PubMed ID: 27886184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LONGITUDINAL OPTICAL COHERENCE TOMOGRAPHY-ANGIOGRAPHY STUDY OF TYPE 2 NAIVE CHOROIDAL NEOVASCULARIZATION EARLY RESPONSE AFTER TREATMENT.
    Lumbroso B; Rispoli M; Savastano MC
    Retina; 2015 Nov; 35(11):2242-51. PubMed ID: 26457401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization.
    Spaide RF
    Am J Ophthalmol; 2015 Jul; 160(1):6-16. PubMed ID: 25887628
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.